Sarah E Bota Selected Research

polystyrene sulfonic acid (sodium polystyrene sulfonate)

1/2021	Ambulatory Treatments for RAAS Inhibitor-Related Hyperkalemia and the 1-Year Risk of Recurrence.
1/2019	Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah E Bota Research Topics

Disease

4	Hemorrhage 01/2017 - 01/2014
3	Chronic Renal Insufficiency 11/2022 - 01/2017
3	Hyperkalemia 08/2022 - 01/2019
2	Neoplasms (Cancer) 11/2022 - 01/2018
1	Chronic Pain 11/2022
1	Heart Diseases (Heart Disease) 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 12/2021
1	Toxic Megacolon 12/2021
1	Ileus 12/2021
1	Proteinuria 09/2021
1	Heart Failure 01/2020
1	Dementia (Dementias) 01/2020
1	Thrombosis (Thrombus) 01/2019
1	Ischemia 01/2019
1	ST Elevation Myocardial Infarction 10/2018
1	Non-ST Elevated Myocardial Infarction 10/2018
1	Ischemic Stroke 01/2017
1	Atrial Fibrillation 01/2017

Drug/Important Bio-Agent (IBA)

3	AlbuminsIBA 09/2021 - 01/2016
3	CreatinineIBA 09/2021 - 01/2016
2	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 01/2021 - 01/2019
1	Opioid Analgesics (Opioids)IBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 09/2021
1	DiureticsIBA 01/2021
1	PotassiumIBA 01/2021
1	AnticoagulantsIBA 01/2017
1	Warfarin (Coumadin)FDA LinkGeneric 01/2014
1	Clopidogrel (Plavix)FDA Link 01/2014

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2020 - 01/2018
1	Terminal Care (Care, Terminal) 11/2022
1	Therapeutics 08/2022
1	Colectomy 12/2021
1	Peritoneal Dialysis 01/2020
1	Long-Term Care 01/2020
1	Ostomy 01/2019
1	Kidney Transplantation 01/2015